Dinghong Xiao

Dinghong Xiao

Auto-generated profile, based on publicly available information

Dinghong Xiao

Department of 2nd Gastroenterology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, No. 725, Wanping South Road, Xuhui District, Shanghai 200032, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2014 in Journal of Clinical Pharmacy and Therapeutics
Verified
Journal Article
Closed access
PDF file
XTX. Tong
X. Tong
DXD. Xiao
D. Xiao
FYF. Yao
F. Yao
THT. Huang
T. Huang
What is known and objective Astragalus membranaceus, one of the most common Chinese herbs, is widely used to prevent and treat a variety of diseases. Very few adverse reactions, caused by A. membranaceus, have been reported in the literature. The purpose of this article was to report a case of marked increase in carbohydrate antigen 19‐9 (CA19‐9) and the formation of liver and kidney cysts following oral administration of A. membranaceus. Case summary A 38‐year‐old woman was found to have a high serum CA19‐9 level (156 U/mL) at her routine annual examination. On follow‐up, several small cysts were found in her left kidney and liver by CT scan. Her medical history showed that she had taken Astragalus tea every day for 1 month. One month after she stopped taking it, the CA19‐9 level decreased to 40·19 U/mL. Ten months later, PET‐CT showed that there were no liver and kidney cysts. However, she took Astragalus powder again in the second year and 1 month later her CA19‐9 level increased again to more than 1000 U/mL. Several small cysts were again seen in her left kidney and liver by enhanced CT. Her CA19‐9 level gradually became normal after she stopped taking the Astragalus powder. What is new and conclusion This case strongly suggests that oral administration of A. membranaceus may lead to increase in CA19‐9 and the formation of liver and kidney cysts.

18 March 2026 in Cancers
Verified
Journal Article
Open access
PDF file
LHLin He
Lin He
XYXiao Yv
Xiao Yv
DXDing-Hong Xiao
Ding-Hong Xiao
HZHai-Yan Zhang
Hai-Yan Zhang
LXLian-jun Xing
Lian-jun Xing
ZLZhidong Liu
Zhidong Liu
The etiology of gastric cancer (GC) is increasingly defined by the complex interplay within the oral-gastric microbial axis. This conceptual shift extends beyond the classical Helicobacter pylori (H. pylori) model. Instead, it encompasses a broader polymicrobial network. Mechanisms underlying ectopic colonization of oral pathobionts are examined alongside their synergistic contributions to mucosal dysbiosis. Remodeling of the tumor microenvironment is discussed through the analysis of critical functional modules, including biofilm formation, metabolic reprogramming, and immune dysregulation. Carcinogenesis is reportedly promoted by specific genotoxic metabolites and perpetuation of chronic inflammation. Diagnostic capabilities are evaluated with a focus on noninvasive biomarkers, where integration of artificial intelligence for risk stratification is identified as a transformative tool for early detection. Furthermore, therapeutic perspectives are expanded by evidence linking microbial composition to the efficacy of immune checkpoint inhibitors and chemotherapy. Strategies for prevention and treatment are proposed based on restoration of microbial homeostasis. Collectively, a roadmap for translating microbiome research into personalized clinical practice for gastrointestinal malignancies is provided by this review.

27 March 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
XHXiaobo Huang
Xiaobo Huang
XTXin Tong
Xin Tong
LXLianjun Xing
Lianjun Xing
DXDinghong Xiao
Dinghong Xiao